{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:14:17Z","timestamp":1773281657437,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Senju Pharmaceutical Co., Ltd."}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.ejphar.2016.05.012","type":"journal-article","created":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T14:00:22Z","timestamp":1463061622000},"page":"43-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["In vitro and in vivo corneal effects of latanoprost combined with brimonidine, timolol, dorzolamide, or brinzolamide"],"prefix":"10.1016","volume":"787","author":[{"given":"Masamichi","family":"Fukuda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teppei","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhisa","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2016.05.012_bib1","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1007\/s12325-009-0076-8","article-title":"The effects of combination glaucoma medications on ocular surface epithelial cells","volume":"26","author":"Ammar","year":"2009","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ejphar.2016.05.012_bib2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2147\/OPTH.S9716","article-title":"Incidence, severity and factors related to drug-induced keratoepitheliopathy with glaucoma medications","volume":"4","author":"Fukuchi","year":"2010","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.ejphar.2016.05.012_bib3","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2147\/OPTH.S30935","article-title":"Quantitative evaluation of corneal epithelial injury caused by n-heptanol using a corneal resistance measuring device in vivo","volume":"6","author":"Fukuda","year":"2012","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.ejphar.2016.05.012_bib4","first-page":"515","article-title":"Safety comparison of additives in antiglaucoma prostaglandin (PG) analog ophthalmic formulations clinical","volume":"7","author":"Fukuda","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejphar.2016.05.012_bib5","first-page":"849","article-title":"Generic versions of latanoprost ophthalmic solution evaluated for safety to corneal epithelial cells","volume":"28","author":"Fukuda","year":"2011","journal-title":"Atarashii Ganka (J. Eye)"},{"key":"10.1016\/j.ejphar.2016.05.012_bib6","first-page":"977","article-title":"Cytotoxic effect of ofloxacin ophthalmic solutions and timolol maleate ophthalmic solutions on cultured rabbit corneal cell line and ocular pharmacokinetics of ophthalmic solutions in rabbits","volume":"26","author":"Fukuda","year":"2009","journal-title":"Atarashii Ganka (J. Eye)"},{"key":"10.1016\/j.ejphar.2016.05.012_bib7","first-page":"441","article-title":"A multicenter evaluation of ocular surface disease prevalence in patients with glaucoma","volume":"6","author":"Garcia-Feijoo","year":"2012","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.ejphar.2016.05.012_bib8","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1080\/10715760410001712773","article-title":"A comparison of the effects of ocular preservatives on mammalian and microbial ATP and glutathione levels","volume":"38","author":"Ingram","year":"2004","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.ejphar.2016.05.012_bib9","first-page":"195","article-title":"Effects of anti-glaucoma eye drops on rabbit corneal epithelial cells","volume":"31","author":"Inoue","year":"2003","journal-title":"J. St. Marian. Univ."},{"key":"10.1016\/j.ejphar.2016.05.012_bib10","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/IJG.0b013e31815c5f4f","article-title":"Prevalence of ocular surface disease in glaucoma patients","volume":"17","author":"Leung","year":"2008","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.ejphar.2016.05.012_bib11","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1248\/yakushi.131.985","article-title":"An in vitro evaluation for corneal damages by anti-glaucoma combination eye drops using human corneal epithelial cell (HCE-T)","volume":"131","author":"Nagai","year":"2011","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.ejphar.2016.05.012_bib12","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.1167\/iovs.12-9685","article-title":"Toxicity evaluation of antiglaucoma drugs using stratified human cultivated corneal epithelial sheets","volume":"53","author":"Nakagawa","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejphar.2016.05.012_bib13","doi-asserted-by":"crossref","first-page":"8172","DOI":"10.1167\/iovs.12-10766","article-title":"In vitro and in vivo comparative toxicological study of a new preservative-free latanoprost formulation","volume":"53","author":"Pauly","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejphar.2016.05.012_bib14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/02713683.2011.626909","article-title":"The cytotoxic effects of preserved and preservative-free prostaglandin analogs on human corneal and conjunctival epithelium in vitro and the distribution of benzalkonium chloride homologs in ocular surface tissues in vivo","volume":"37","author":"Pellinen","year":"2012","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ejphar.2016.05.012_bib15","first-page":"547","article-title":"Characteristic of brimonidine tartrate ophthalmic solution (AIPHAGAN 0.1%)","volume":"67","author":"Wada","year":"2012","journal-title":"Igaku Yakugaku"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916303181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916303181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T22:57:00Z","timestamp":1536706620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299916303181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":15,"alternative-id":["S0014299916303181"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.05.012","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro and in vivo corneal effects of latanoprost combined with brimonidine, timolol, dorzolamide, or brinzolamide","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}